190 related articles for article (PubMed ID: 7509774)
1. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
Adlakha H; Bostwick DG
Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
[TBL] [Abstract][Full Text] [Related]
2. Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Weaver MG; Abdul-Karim FW; Srigley J; Bostwick DG; Ro JY; Ayala AG
Am J Surg Pathol; 1992 Jan; 16(1):62-8. PubMed ID: 1370193
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Constantinides C; Pavlaki K; Zizi D; Gavriel J; Mitropoulos D; Garifalos J; Dimopoulos C
Urol Int; 1995; 55(3):134-6. PubMed ID: 8540155
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
Bostwick DG; Dousa MK; Crawford BG; Wollan PC
Am J Surg Pathol; 1994 Dec; 18(12):1240-6. PubMed ID: 7977947
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
Tamas EF; Epstein JI
Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
[TBL] [Abstract][Full Text] [Related]
8. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation.
Weaver MG; Abdul-Karim FW; Srigley JR
Am J Surg Pathol; 1992 Oct; 16(10):1013-6. PubMed ID: 1329569
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in prostate cancer.
Cerović SJ; Brajusković GR; Vukotić Maletić VD; Mićić SR
Vojnosanit Pregl; 2004; 61(5):513-8. PubMed ID: 15551804
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and neuroendocrine features of adenocarcinoma arising in the transition zone and in the peripheral zone of the prostate.
Van de Voorde WM; Van Poppel HP; Verbeken EK; Oyen RH; Baert LV; Lauweryns JM
Mod Pathol; 1995 Aug; 8(6):591-8. PubMed ID: 8532689
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
13. Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Ghannoum JE; DeLellis RA; Shin SJ
Int J Surg Pathol; 2004 Apr; 12(2):167-70. PubMed ID: 15173926
[TBL] [Abstract][Full Text] [Related]
14. Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies.
Van de Voorde WM; Elgamal AA; Van Poppel HP; Verbeken EK; Baert LV; Lauweryns JM
Cancer; 1994 Dec; 74(12):3164-75. PubMed ID: 7526970
[TBL] [Abstract][Full Text] [Related]
15. Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5.
So JS; Gordetsky J; Epstein JI
Hum Pathol; 2014 Dec; 45(12):2388-93. PubMed ID: 25277321
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Zhang ZF; Bazinet M; Hamdy SM; Reuter VE
J Urol; 1994 Apr; 151(4):914-9. PubMed ID: 8126824
[TBL] [Abstract][Full Text] [Related]
17. Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation.
Civantos F
Mol Urol; 2000; 4(3):117-21; discussion 123. PubMed ID: 11062365
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Sauvageot J; Epstein JI
Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]